Temozolomide NEW

Price	$32	$1.3
Package	1KG	1000KG

Min. Order:	1KG
Supply Ability:	g-kg-tons, free sample is available
Update Time:	2024-04-15

Product Details

Product Name: Temozolomide	CAS No.: 85622-93-1
Min. Order: 1KG	Purity: 99%
Supply Ability: g-kg-tons, free sample is available	Release date: 2024/04/15
Name: Mia	COA, MSDS: Available, contact us for details
Origin: Manufacturer, advantage product	Delivery: By express, by air, by sea
Packaging: bag/bottle/drum/IBC	Lead time: In stock, ready for shipment

1. Materials information

Name	temozolomide
Synonym	More Synonyms

Description	Temozolomide (NSC 362856; CCRG 81045) is an oral DNA alkylating agent used to treat some brain cancers.
Related Catalog	Signaling Pathways >> Autophagy >> Autophagy Signaling Pathways >> Cell Cycle/DNA Damage >> DNA Alkylator/Crosslinker Research Areas >> Cancer
Target	DNA alkylator[1]
In Vitro	Temozolomide (TZM) is a methylating agent that crosses the blood-brain barrier and is indicated for malignant gliomas and metastatic melanomas. Temozolomide is effective against tumor cells that are characterized by low levels of O6-alkylguanine DNA alkyltransferase (OGAT) and a functional mismatch repair system (MR)[1]. Determination of the IC50 for Temozolomide (TZM) in different cell lines gave values ranging from 14.1 to 234.6 μM that fell into two clearly differentiated groups: cell lines with low IC50 values (<50 μM), which include A172 (14.1±1.1 μM) and LN229 cells (14.5±1.1 μM), and those with high IC50 values (>100 μM), which include SF268 (147.2±2.1 μM) and SK-N-SH cells (234.6±2.3 μM)[2].
In Vivo	Temozolomide (TZM), as a single agent, does not significantly increase mdian survival time (MST) with respect to control. Noteworthy, intracranial injection of NU1025, immediately before the administration of 100 or 200 mg/kg Temozolomide, significantly increases lifespans with respect to controls or to groups treated with Temozolomide only. When Temozolomide is fractionated, the increase in lifespan (ILS) obtained with this schedule is higher than that observed when NU1025 is combined with a single injection of Temozolomide (statistical comparison of survival curves: NU1025 intracranially+Temozolomide 100 mg/kg×2 vs NU1025+Temozolomide 200 mg/kg; P=0.023)[1].
Cell Assay	The murine lymphoma cell line L5178Y of DBA/2 (H-2d/H-2d) origin is cultured in RPMI-1640 containing 10% fetal calf serum and antibiotics. Inhibition of PARP is obtained by treating cells (105 cells/mL) with 8-hydroxy-2-methylquinazolin-4[3H]-1 (NU1025), at a concentration (25 μM) that abrogates PARP activity. Cells are then exposed to Temozolomide (7.5-125 μM) and are cultured for 3 days. Cell growth is evaluated by counting viable cells in quadruplicate, and apoptosis is assessed by flow cytometry analysis of DNA content. Long-term survival is analyzed by colony-formation assay[1].
Animal Admin	Mice[1] Male B6D2F1 (C57BL/6×DBA/2) mice are anesthetized with ketamine (100 mg/kg) and xylazine (5 mg/kg) in 0.9% NaCl solution (10 mL/kg intraperitoneally). L5178Y cells (104 in 0.03 mL RPMI-1640) are then injected intracranially, through the center-middle area of the frontal bone to a 2-mm depth, using a 0.1-mL glass microsyringe and a 27-gauge disposable needle. To evaluate tumor cell growth, brains are fixed in 10% phosphate-buffered formaldehyde, and histologic sections (5 μm) are cut along the axial plane, stained with hematoxylin-eosin, and analyzed by light microscopy. Temozolomide is dissolved in DMSO (40 mg/mL), diluted in saline (5 mg/mL), and administered intraperitoneally on day 2 after tumor injection at 100 mg/kg or 200 mg/kg, doses commonly used for in vivo preclinical studies. Because cytotoxicity induced by Temozolomide and PARP inhibitors can be improved by fractionated modality of treatment, in selected groups a total dose of 200 mg/kg Temozolomide is divided in 2 doses of 100 mg/kg given on days 2 and 3.
References	[1]. Tentori L, et al. Combined treatment with temozolomide and poly(ADP-ribose) polymerase inhibitor enhances survival of mice bearing hematologic malignancy at the central nervous system site. Blood. 2002 Mar 15;99(6):2241-4. [2]. Perazzoli G, et al. Temozolomide Resistance in Glioblastoma Cell Lines: Implication of MGMT, MMR, P-Glycoprotein and CD133 Expression. PLoS One. 2015 Oct 8;10(10):e0140131.

Density	2.0±0.1 g/cm3
Boiling Point	526.6±42.0 °C at 760 mmHg
Melting Point	212°C dec.
Molecular Formula	C6H6N6O2
Molecular Weight	194.151
Flash Point	272.3±27.9 °C
Exact Mass	194.055222
PSA	108.17000
LogP	-1.32
Vapour Pressure	0.0±1.4 mmHg at 25°C
Index of Refraction	1.895
Storage condition	2-8°C

Temozolomide MSDS(Chinese)

CHEMICAL IDENTIFICATION

RTECS NUMBER :
NJ5927050

CHEMICAL NAME :
Imidazo(5,1-d)(1,2,3,5)tetrazine-8-carboxamide, 3,4-dihydro-3-methyl-4-oxo-

CAS REGISTRY NUMBER :
85622-93-1

LAST UPDATED :
199612

DATA ITEMS CITED :
3

MOLECULAR FORMULA :
C6-H6-N6-O2

MOLECULAR WEIGHT :
194.18

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LDLo - Lowest published lethal dose

ROUTE OF EXPOSURE :
Intraperitoneal

SPECIES OBSERVED :
Rodent - mouse

DOSE/DURATION :
125 mg/kg

TOXIC EFFECTS :
Tumorigenic - active as anti-cancer agent

MUTATION DATA

TYPE OF TEST :
DNA damage

TEST SYSTEM :
Rodent - mouse Leukocyte

DOSE/DURATION :
100 umol/L

REFERENCE :
CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- Volume(issue)/page/year: 47,4884,1987

Symbol	GHS07, GHS08
Signal Word	Danger
Hazard Statements	H302-H315-H319-H335-H350-H360
Precautionary Statements	P201-P261-P305 + P351 + P338-P308 + P313
Personal Protective Equipment	Eyeshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges
Hazard Codes	T: Toxic;Xi: Irritant;
Risk Phrases	R45
Safety Phrases	S24/25-S45-S36/37-S26-S53
RIDADR	NONH for all modes of transport
RTECS	NJ5927050
HS Code	2933990090

2. Packaging of materials

For powders: normal is 25kgs/Drum or bag, or larger/smaller package as request.
For liquids: normal 25kgs/drum, 180-300kgs/bucket, or IBC, determined by the nature of the product.

Or smaller package 1kg/bottle, 10kgs/bottle as request.

Article illustration

3. Shipping & Delivery

By Express

Provide door to door service

Suitable for goods under 50kg

Delivery: 3-7 days

Cost: low cost

Article illustration

By Air

Provide airport to airport service

Suitable for goods over 50kg

Delivery: 3-14 days

Cost: high cost

Article illustration

By Sea

Provide seaport to seaport service

Suitable for goods over 100kg

Delivery: 2-45 days

Cost: low cost

Article illustration

4. Contact information

For more details, pls contact us freely.

Email address: mia@fdachem.com

Mob: 86 18336764634

WhatsApp/Skype/Wechat/LINE: 86 18336764634

Company Profile Introduction

Henan Fengda Chemical Co., Ltd. is located in the High-tech Development Zone of Henan Province. Specializing in the production and sales of various fine chemical products required for industrial production, including chemical raw materials, organic raw materials, petrochemicals, chemical reagents, solvents, catalysts, and additives, etc.

Recommended supplier

Product name	Price		Suppliers	Update time
Temozolomide	$10.00/1KG	VIP6Y	Hebei Weibang Biotechnology Co., Ltd	2024-12-03
Temozolomide	$42.00/10mg	VIP5Y	TargetMol Chemicals Inc.	2024-11-19
Temozolomide	$42.00/10mg	VIP3Y	TargetMol Chemicals Inc.	2024-11-19
Temozolomide	$10.00/1kg	VIP4Y	Hebei Chuanghai Biotechnology Co,.LTD	2024-08-20
Temozolomide	$0.00/1g	VIP1Y	BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.	2024-08-09
Temozolomide	$40.00/10mg	VIP2Y	Zibo Hangyu Biotechnology Development Co., Ltd	2024-07-10
Temozolomide	$5.00/25kg		Ouhuang Engineering Materials (Hubei) Co., Ltd	2024-04-28
Temozolomide	$50.00/1kg	VIP5Y	Hebei Yanxi Chemical Co., Ltd.	2023-09-22
Temozolomide	$0.00/25KG	VIP5Y	Hebei Mojin Biotechnology Co., Ltd	2022-07-12
Temozolomide	$15.00/1kg		Hebei Linwo New Material Technology Co., LTD	2022-06-27